Nanomedicines continue to accelerate the forefront of drug delivery technologies. Inorganic mesoporous silica nanoparticles are a driving force with their unique and superlative properties. Recently, formulation researches with mesoporous silica nanoparticles have advanced many drug delivery systems, including liposome, microsphere, oro-dispersible film, 3D-printed formulation, and microneedle.
Dipy Vasa from Pfizer focuses this talk on mesoporus silica solubility-enabling technology background and examples, her teams current work, experimental setup, controlling drug release with HPMCAS and potential applications to this approach.
FREE WEBINAR: Tuning Drug Release from Mesoporus Silica Particles: Impact of HPMCAS Polymer
Dipy Vasa, PhD
Senior Scientist, Drug Product Design
2024 Controlled & Modified Drug Release Summit
(May 14-15, 2024, Princeton, NJ)